Literature DB >> 21738293

Utility of pattern recognition in the detection of unsuspected additional primary malignancies on positron emission tomography-computed tomography.

Erin M Bowman1, Umesh D Oza, Hamid R Latifi.   

Abstract

Positron emission tomography-computed tomography (PET-CT) has been shown to detect unexpected synchronous malignancies in up to 4.8% of patients and has been shown to be more sensitive than conventional staging alone. Detection of an unsuspected synchronous malignancy on PET-CT will often affect both patient treatment and prognosis. This article reviews expected patterns of disease spread so that a synchronous malignancy can be more easily recognized.

Entities:  

Year:  2011        PMID: 21738293      PMCID: PMC3124905          DOI: 10.1080/08998280.2011.11928717

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  12 in total

Review 1.  PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.

Authors:  Lale Kostakoglu; Ruth Hardoff; Rosna Mirtcheva; Stanley J Goldsmith
Journal:  Radiographics       Date:  2004 Sep-Oct       Impact factor: 5.333

2.  Normal FDG distribution patterns in the head and neck: PET/CT evaluation.

Authors:  Yuji Nakamoto; Mitsuaki Tatsumi; Dima Hammoud; Christian Cohade; Medhat M Osman; Richard L Wahl
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

3.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.

Authors:  M P Stokkel; F W ten Broek; G J Hordijk; R Koole; P P van Rijk
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

4.  Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.

Authors:  Joon Young Choi; Kyung Soo Lee; O Jung Kwon; Young Mog Shim; Chung-Hwan Baek; Keunchil Park; Kyung-Han Lee; Byung-Tae Kim
Journal:  J Clin Oncol       Date:  2005-10-20       Impact factor: 44.544

Review 5.  Clinical role of FDG PET in evaluation of cancer patients.

Authors:  Lale Kostakoglu; Harry Agress; Stanley J Goldsmith
Journal:  Radiographics       Date:  2003 Mar-Apr       Impact factor: 5.333

6.  Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.

Authors:  Keon Wook Kang; Seok-Ki Kim; Han-Sung Kang; Eun Sook Lee; Jung Suk Sim; In Goo Lee; Seung-Yong Jeong; Sun Wook Kim
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

7.  Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.

Authors:  S Adams; R P Baum; T Stuckensen; K Bitter; G Hör
Journal:  Eur J Nucl Med       Date:  1998-09

8.  Incidental PET/CT findings in the cancer patient: how should they be managed?

Authors:  John S Beatty; Hadyn T Williams; Beau A Aldridge; Matthew P Hughes; Viren S Vasudeva; Angela L Gucwa; George S David; D Scott Lind; E James Kruse; James M McLoughlin
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

Review 9.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.

Authors:  P D Shreve; Y Anzai; R L Wahl
Journal:  Radiographics       Date:  1999 Jan-Feb       Impact factor: 5.333

10.  Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.

Authors:  Rachel Bar-Shalom; Nikolai Yefremov; Ludmila Guralnik; Diana Gaitini; Alex Frenkel; Abraham Kuten; Hernan Altman; Zohar Keidar; Ora Israel
Journal:  J Nucl Med       Date:  2003-08       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.